

Senior Director, Windmill Capital | The content in this article is purely the author’s personal opinion and is for informational and educational purposes only. It should not be construed as professional financial advice and nor to be construed as an offer to buy /sell or the solicitation of an offer to buy / sell any security or financial products.
The views and opinions stated in the content belong to the author. Windmill Capital Private Limited does not uphold nor promote any of the views / opinions. | Windmill Capital Private Limited is a SEBI registered research analyst (Regn. No. INH200007645)

We upgraded the CANSLIM-esque smallcase with asset allocation—same growth, lower drawdowns. Here’s the why.

This article decodes the math behind Washington’s tariff strategy, and evaluates how different Indian sectors may be impacted.

India Hit by 26% US Tariff; Markets Slide as Global Trade Tensions Escalate.

The U.S. is targeting India’s trade surplus with new tariffs. The high-value pharmaceutical sector now risks major disruption.

On a daily basis, we receive multiple queries from our investors on…

Our latest data shows a surprising twist — many low-growth companies in Q4 are trading at higher valuations than their faster-growing peers, catching the market’s attention.